The Relationship between Knowledge Level and the Roleof Supervisors of Medication Taking (PMO) and Medication Compliance in Tuberculosis (TB) Patients at the Binong Community Health Center in KabupatenTangerang and Its Impact on Patient Quality of life
DOI:
https://doi.org/10.35451/jfm.v9i1.3791Keywords:
Tuberculosis, Knowledge Level, Treatment Supervisor, Medication Adherence, Quality Of LifeAbstract
Background: Tuberculosis (TB) remains a major public health challenge in Indonesia. Treatment success is influenced by several factors, including patients' knowledge, the role of Treatment Supervisors (TS), medication adherence, and quality of life. Objective: To analyze the relationship between patients' knowledge and the role of Treatment Supervisors (TS) with medication adherence, as well as the relationship between medication adherence and the quality of life of TB patients at Binong Primary Health Center, Tangerang Regency. Methods: This quantitative study employed a cross-sectional design involving 120 respondents selected using total sampling. Data were collected using knowledge, Treatment Supervisor (TS), MMAS-8, and WHOQOL-BREF questionnaires and analyzed using the Chi-square test. Results: Most respondents had good knowledge (71.7%), supportive Treatment Supervisor (TS) roles (98.3%), moderate medication adherence (55.0%), and good quality of life (90.0%). Significant associations were found between knowledge and medication adherence (p=0.000), the role of Treatment Supervisors and medication adherence (p=0.043), and medication adherence and quality of life (p=0.029). Conclusion: Patients' knowledge and the role of Treatment Supervisors were significantly associated with medication adherence, while medication adherence was significantly associated with the quality of life of TB patients at Binong Primary Health Center, Tangerang Regency.
Downloads
References
[1] Dipiro, J., Yee, G., Haines, S., Nollin, T., Ellingrof, V., & Posey, M. (2023). Dipiro’s 12 Th Edition Pharmacotherapy A Pathophysiologic Approach (12th Editi). Mcgraw Hill.
[2] Kemenkes Ri. (2024). Laporan Hasil Studi Inventori Tuberkulosis Indonesia 2023-2024 (1st Ed.). Kemenkes Ri.
[3] Kemenkes Ri. (2020b). Pedoman Nasional Pelayanan Kedokteran “Tata Laksana Tuberkulosis.” In Kementerian Kesehatan Republik Indonesia, Jakarta.
[4] Saragih, A. M. L., Indriyani, E., Ashri, R. H., & Syaefudin, A. (2024). Hubungan Peran Pengawas Minum Obat (Pmo) Dengan Kepatuhan Minum Obat Pada Pasien Tb Paru Di Rs. Ml Ciledug. Medical Nurse Journal (Menu), 1(2), 42–54.
[5] Nabila, J., Fitriangga, A., & Putri, E. A. (2026). Hubungan Fase Pengobatan Dengan Kualitas Hidup Pasien Tb Di Puskesmas Perumnas I Pontianak , Indonesia. Cdk-349, 53(02), 66–70.
[6] Widodo, S., Ladyani, F., Asrianto, L. O., Rusdi, Khairunnisa, Lestari, S. M. P., Wijayanti, D. R., Devriany, A., Hidayat, A., Dalfian, Nurcahyati, S., Sjahriani, T., Armi, Widya, N., & Rogayah. (2023). Metodologi Penelitian. In Cv Science Techno Direct (1st Ed.). Cv Science Techno Direct.
[7] Wulandari, R. A., Natashia, D., & Fitria, D. (2025). Faktor-Faktor Yang Mempengaruhi Kepatuhan Pengobatan Tb Paru Di Puskesmas Kemayoran. Jurnal Ilmiah Keperawatan (Scientific Journal Of Nursing), 11(2), 1–6.
[8] Nurgiansyah, A. I., Muflihah, H., & Ekowati, R. (2024, February). Hubungan antara karakteristik pasien dengan keberhasilan pengobatan tuberkulosis (TB) paru di UPTD Puskesmas Caringin tahun 2020–2022. In Bandung Conference Series: Medical Science (Vol. 4, No. 1, pp. 91-98).
[9] NOTOATMODJO, Soekidjo; KASIMAN, Sutomo; KINTOKO ROHADI, R. Patient’s Behaviour with Coronary heart desease Viewed from Socio-Cultural aspect of Aceh Society in Zainoel Abidin Hospital. In: MATEC Web of Conferences. EDP Sciences, 2018. p. 05065.
[10] Rahmawati, A., Maulina Wulandari, S., Milanti, A., Efendi, F., Maryuni, M., Mutia, J., & Ravica Aprilia, N. (2024). Knowledge, perception, and stigma in the jakarta community toward tuberculosis prevention.
[11] Muflihah, H., Yulianto, F. A., Sampurno, E., Ferdiana, A., & Rahimah, S. B. (2024). Tuberculosis coinfection among COVID-19 patients: Clinical presentation and mortality in a tertiary Lung Hospital in Indonesia. The International Journal of Mycobacteriology, 13(1), 58-64.
[12] Sari, N. P. (2025). Socioeconomic status and healthcare support on anti-tuberculosis medication adherence among pediatric tuberculosis patients. Frontiers on Healthcare Research, 2(1), 30-36.
[13] Nabila, J., Fitriangga, A., & Putri, E. A. (2026). Hubungan Fase Pengobatan Dengan Kualitas Hidup Pasien Tb Di Puskesmas Perumnas I Pontianak , Indonesia. Cdk-349, 53(02), 66–70.
[14] Sari, M. T., Efni, N., Putri, M. E., & Alfajri, J. (2025). Eliminasi TB Paru dengan Deteksi Dini menggunakan Self Screening di Kelurahan Legok Kota Jambi. Jurnal Pengabdian Harapan Ibu (JPHI), 7(3), 324-331.
[15] Yani, D. I., et al. (2025). Assessing Quality of life in Patients with New and Recurrent Pulmonary Tuberculosis.
[16] Kodical, S. P., Roy, R., Shetty, D., et al. (2025). Exploring factors influencing the health-related quality of life of tuberculosis patients: A WHOQOL-BREF-based study. Monaldi Archives for Chest Disease.
[17] Rima, U. S., Islam, J., Mim, S. I., Roy, A., Dutta, T., Dutta, B., & Ferdaus, F. F. (2024). Co-Infection of Tuberculosis and Diabetes: Implications for Treatment and Management. Asia Pacific Journal of Surgical Advances, 1(2), 51-58.
[18] Prahastuti, B. S., Endarti, A. T., & Solikhin, M. H. (2025). Validity And Reliability Test Of The Whoqol-Hiv Bref Instrument On Plhiv In Bandar Lampung City In 2025. Jurnal Kesehatan Masyarakat Perkotaan, 5(2), 556–564.
[19] Sinulingga, A. S., Situmorang, N. B., & Siregar, M. G. (2021). Evaluasi Penggunaan Obat Antituberkulosis (Oat) Pada Pasien Tb Paru Di Rumah Sakit Grandmed Lubuk Pakam Tahun 2020. Jurnal Farmasimed (Jfm), 3(2), 69-73.
[20] Afriani, T., & Jannah, M. (2026). Association between Medication Adherence, Anxiety, and Quality of life in Pulmonary Tuberculosis Patients: A Cross-Sectional Study. JURNAL FARMASIMED (JFM), 8(2), 1193-1202.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Chairunnisa Harahap, Satya Candra Indra Yanih
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright in each article is the property of the Author.
